Nilay Shah, MD
College of Medicine
Asst Professor - Clinical
Molecular Biology and Cancer Genetics
Cancer ● Neuroblastoma ● Breast Cancer ● Sarcoma, Ewing ● Precursor Cell Lymphoblastic Leukemia-Lymphoma ● Neoplasm Metastasis ● DNA Damage
Nilay Shah, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where his research focuses on embryonic cancers, particularly neuroblastomas.Dr. Shah seeks to identify biomarkers of disease severity to better distinguish between low-risk patients who will need chemotherapy and high-risk patients who will not respond to available treatments. This information will also lead to novel therapeutic targets to improve outcomes and reduce toxicity. One of his recent studies examines components of the HOX gene pathway, which has led to identifying several targets for further validation and could, in turn, guide treatment approaches. Dr. Shah has co-authored numerous articles in well-known publications, including Cancer Research, Pediatric Blood & Cancer, Clinical Cancer Research and American Journal of Managed Care.